It has been demonstrated that calcitonin-binding sites are present in a variety of tissue types, including in the pituitary gland. Interleukin-6 (IL-6) is also produced in the pituitary and it regulates the secretion of various hormones. In this study, we examined the expression of the calcitonin receptor and the mechanism of IL-6 production induced by calcitonin in the pituitary folliculo-stellate cell line (TtT/GF). The mRNA of calcitonin receptor subtype C1a, but not that of C1b, was detected by RT-PCR in TtT/GF cells and in the normal mouse pituitary. Calcitonin increased cAMP accumulation and IL-6 production in a concentration-dependent manner in TtT/GF cells. As calcitonin activates the PKA and PKC pathways, we investigated the contributions of PKA and PKC to IL-6 production. IL-6 production was only slightly increased by either 8-bromo-cAMP (1 mM) or phorbol 12-myristate 13-acetate (100 nM) alone. However, IL-6 was synergistically induced in the presence of both 8-bromo-cAMP (1 mM) and phorbol 12-myristate 13-acetate (100 nM). Furthermore, calcitonininduced IL-6 production was completely suppressed by H-89 (PKA inhibitor) or GF109203X (PKC inhibitor), indicating that the activation of both PKA and PKC is necessary for calcitonin-induced IL-6 production. On the other hand, pertussis toxin (G i /G o signaling inhibitor) treatment achieved an approximately 9-fold increase in calcitonin-induced IL-6 production. These results show that calcitonin-stimulated IL-6 production is mediated via both PKA-and PKC-signaling pathways, whereas calcitonin also suppresses IL-6 production by activating G i /G o proteins in folliculo-stellate cells.
C ALCITONIN (CT) IS a 32-amino acid peptide hormone that regulates blood Ca 2ϩ concentrations by inhibiting bone reabsorption. CT is mainly synthesized in the parafollicular cells of the thyroid gland and is secreted into blood (1) . Binding sites for CT are distributed among many cell and tissue types, including osteoclasts, kidney, brain, and pituitary (2) (3) (4) (5) (6) . The CT receptor (CTR) belongs to a subclass of the G protein-coupled receptor family that includes PTH/ PTHrP, secretin, VIP, pituitary adenylate cyclase-activating polypeptide (PACAP), CRF, etc. (7) (8) (9) . Two isoforms of rodent CTRs, C1a and C1b, have been identified to date, and they have been shown to differ according to the absence or presence of a 37-amino acid insert in the second extracellular domain (10, 11) . The CTR is able to couple to G s , G q , and G i proteins (12) (13) (14) and activates adenylyl cyclase, PLC (15, 16) , and PLD (17) . PKA, PKC, and MAPK are all involved in the CTR signaling pathways (18, 19) .
IL-6 controls the secretion of ACTH, PRL, GH, and LH from the anterior pituitary (20, 21) . Moreover, IL-6 mRNA and IL-6 have been detected in the pituitary (22, 23) and are localized to folliculo-stellate (FS) cells (24, 25) . IL-6 production is regulated via various signaling pathways, including both the PKA and PKC pathways (26 -28) .
FS cells of the anterior pituitary gland are of the agranular cell type and have a stellate morphology and surrounding follicular cavities (29) . About 7.5% of the cells in the mouse pituitary are FS cells (25) . FS cells have some features in common with glial cells, e.g. expression of GFAP, S100, and vimentin (30) . The TtT/GF cell line, which was established by Inoue et al. from a mouse thyrotropic pituitary tumor, has been shown to possess many features of normal FS cells (31) . TtT/GF cells produce IL-6 in response to VIP, PACAP, and TNF␣ (32, 33) . Moreover, CT, like VIP and PACAP, stimulated cAMP accumulation and subsequent release of IL-6 production from glioma cells (34) . These findings suggest the presence of the CTR and also imply that CT induces IL-6 production in FS cells.
In the present study we examined the effects of CT on IL-6 production in FS cells using H-89, a PKA inhibitor (35); GF109203X, a PKC inhibitor (36); PD98059, a MAPK kinase-1 inhibitor (37); U73122, a PLC/PLD inhibitor (38) ; D609, a phosphatidylcholine (PC)-PLC inhibitor (39) ; propranolol, a phosphatidic, phosphohydrolase (PPH) inhibitor (40) ; and pertussis toxin (PTX), a G i /G o protein activation inhibitor (41) . The results show that CT activates both PKA and PKC, resulting in the induction of IL-6 production, whereas CT also suppresses IL-6 production in part by activating PTX-sensitive G proteins.
Abbreviations: CT, Calcitonin; CGRP, calcitonin gene-related peptide; CRLR, CTR-like receptor; CTR, CT receptor; DG, diacylglycerol; FS, folliculo-stellate; PC, phosphatidylcholine; PMA, phorbol 12-myristate 13-acetate; PPH, phosphohydrolase; PTX, pertussis toxin; RAMP, receptor activity-modifying protein; rCGRP, rat CGRP; sCT, salmon CT. 
Materials and Methods Materials

Cells and cell culture
The mouse FS cell line (TtT/GF cell) was obtained from RIKEN Cell Bank (Saitama, Japan). TtT/GF cells were cultured in DMEM supplemented with penicillin G potassium (50 g/ml), streptomycin sulfate (100 g/ml), and heat-inactivated FCS (10%) at 37 C in 5% CO 2 /95% air. Confluent cells were routinely passaged using 0.25% trypsin and 0.05% EDTA in PBS (pH 7.4).
Animals
Adult male BALB/c mice (6 -7 wk old) were acclimated to standard laboratory conditions (12-h light, 12-h dark cycle at 22Ϫ24 C) and were fed laboratory chow and water ad libitum. All of the experimental procedures were approved by the animal care and use committee at Hokkaido University. Four mouse pituitaries were used for RNA extraction.
RT-PCR
Total RNA of TtT/GF cells or the mouse pituitary homogenates were isolated by AGPC methods (42) . The integrity of total RNA was verified by ethidium bromide staining. Reverse transcriptase reactions were performed on 1 g RNA using 200 U SuperScript II reverse transcriptase in the presence of 0.5 g oligo(deoxythymidine) [12] [13] [14] [15] [16] [17] [18] primer, 500 m of each deoxynucleotide triphosphate, 20 U RNASEOUT Recombinant Ribonuclease Inhibitor, 50 mm Tris-HCl, 10 mm dithiothreitol, 75 mm KCl, and 3 mm MgCl 2 in a 20-l volume at 42 C for 1 h. The enzyme was inactivated by heating the samples to 95 C for 5 min. The sense (5Ј-gttgaggttgtgcccaatgga-3Ј) and antisense (5Ј-ccctggaaatgaatcagagag-3Ј) primers for the CTR amplify bands of 656 bp for C1b and 545 bp for C1a. The sense and antisense primers for the CTR are equivalent to the positions of 1114 -1134 and 1749 -1769, respectively, of mouse C1b sequence (GenBank MMU18542). The sense (5Ј-gcagacaacgtgggctccaag-3Ј) and antisense (5Ј-gatgttcagcatgttcagcag-3Ј) primers for 36B4 amplify a band of 447 bp. 36B4 was used as a control for the quality of the cDNA for each PCR reaction. One twentieth of the resulting cDNAs was subjected to PCR reactions in a 50-l reaction mixture containing 300 nm of both sense and antisense primers, 2.6 U enzyme mixture (thermostable Taq and Pwo DNA polymerases), 1.5 mm MgCl 2 , 200 m of each deoxyribonucleotide triphosphate, and 1 ϫ kit buffer. PCR amplification was performed after 5 min of denaturation at 94 C. The cycle consisted of denaturation (45 sec at 94 C), annealing (45 sec at 58 C for the CTR and at 60 C for 36B4), extension (1 min at 72 C), and 7 min of final extension at 72 C after amplification. The CTR was amplified by 35 cycles; 36B4 was amplified by 25 cycles. The PCR products were analyzed on 1.5% agarose gels in the presence of 0.5 mg/ml ethidium bromide. In addition, control PCR reactions were performed with each primer pair on RNA samples that had been incubated in the absence of reverse transcriptase. The PCR products were purified from gels using the Wizard PCR preps DNA Purification System. The identity of the PCR products migrating at the predicted size was verified by direct sequencing using the same primers as those used for the PCR reaction in an ABI 373 DNA sequencer.
cAMP assay
Confluent TtT/GF cells in six-well plates were washed twice and incubated with serum-free DMEM for 14 h. Cells were washed twice and incubated with various agents for 10 min in a final volume of 1 ml modified Tyrode's HEPES buffer [137 mm NaCl, 5 mm KCl, 5 mm glucose, 1 mm CaCl 2 , 1 mm MgCl 2 , and 20 mm HEPES (pH 7.4)] containing 0.1% BSA and 0.3 mm isobutylmethylxanthine at 37 C. The reaction was terminated by the addition of 100 l 1 n HCl. The cAMP content in the supernatant was measured using the cAMP assay kit.
Protein assay
The protein concentration of each sample was determined using the Bradford protein assay (Bio-Rad Laboratories, Inc., Hercules, CA) according to the manufacturer's methodology using BSA as the standard.
IL-6 production
TtT/GF cells were plated at 1 ϫ 10 5 cells/ml into six-well plates and were incubated for 72 h. Cells were washed twice and incubated with serum-free DMEM for 14 h. Unless otherwise indicated, cells were treated with various agents for 6 h after serum-free DMEM incubation. Supernatants obtained by centrifugation (2000 ϫ g, 15 min) were stored at Ϫ80 C and assayed for immunoreactive IL-6 using ELISA kits.
Statistical analysis
The data are expressed as the mean Ϯ sem of at least three independent experiments. Multiple comparisons were examined by ANOVA, followed by the Bonferroni's multiple range test. P Ͻ 0.05 was considered statistically significant.
Results
CTR mRNA expression in TtT/GF cells and the mouse pituitary
RT-PCR was performed using total RNA from TtT/GF cells and the normal mouse pituitary. The two receptors are distinguished by the 111-bp insert present in the C1b receptor, but not in the C1a receptor. As shown in Fig. 1 , the predicted 545-bp product corresponding to the C1a receptor was expressed in both TtT/GF cells and mouse pituitary. In contrast, the predicted 656-bp product corresponding to the C1b receptor was not detected in either TtT/GF cells or mouse pituitary even at 40 cycles (data not shown). Sequencing confirmed that the 545-bp PCR product from TtT/GF cells and mouse pituitary was the C1a isoform of the mouse CTR. 
cAMP accumulation induced by CT
CT, calcitonin gene-related peptide (CGRP) or amylin increased cAMP accumulation in a similar concentrationdependent manner (Fig. 2A) . CGRP and amylin are 37-amino acid peptides and are structurally related to CT. It has been shown that CGRP and amylin cross-react with the CTR (43, 44) . To examine the mechanism of how CT stimulates its own receptor, we observed the inhibitory effects of the following substances on CT-induced cAMP accumulation: CT antagonist, salmon CT (sCT)-(8 -32), CGRP antagonist, rat CGRP (rCGRP)-(8 -37), and amylin antagonist, rat amylin-(8 -37). As shown in Fig. 2B , 100 nm CT-induced cAMP accumulation was reduced to 18 Ϯ 2% by 100 nm sCT- (8 -32) and to 78 Ϯ 6% by 10 m rCGRP-(8 -37), which reduced rCGRP-induced cAMP accumulation to 14 Ϯ 3% (Fig. 2C) . However, 10 m rat amylin-(8 -37), which reduced rat amylin-induced cAMP accumulation to 68 Ϯ 3% (Fig. 2D) , had no effect on rCTinduced cAMP accumulation. sCT-(8 -32) (100 nm), 10 m rCGRP-(8 -37), or 10 m rat amylin-(8 -37) alone did not affect basal cAMP accumulation (data not shown).
IL-6 production induced by CT
To study the time course of the effects of CT on IL-6 production, TtT/GF cells were treated with 1 m CT, and supernatants were collected at various times from 1-24 h after CT treatment. IL-6 production induced by CT in TtT/GF cells was detectable as early as 1 h (17 Ϯ 4.8 pg/ml) and reached a maximum at 6 h (360.4 Ϯ 21.7 pg/ml). IL-6 production then gradually decreased after 6 h (Fig. 3A) . The concentration-dependent effects of CT on IL-6 production were examined 6 h after CT stimulation. The amount of IL-6 production was detectable at concentrations as low as 30 nm CT (9.8 Ϯ 1.5 pg/ml) and rose steadily with 1 m CT (346.3 Ϯ 25.4 pg/ml; Fig. 3B ).
CT-induced IL-6 production requires both PKA and PKC pathways
CT activates the PKA and PKC pathways via the accumulation of cAMP, diacylglycerol (DG), and intracellular Ca 2ϩ (15, 16 ). 8-Bromo-cAMP and PMA were used to examine whether PKA, PKC, or both kinases are involved in the IL-6 production pathways in TtT/GF cells. IL-6 production was slightly increased by 1 mm 8-bromo-cAMP, but was not increased by 100 nm PMA. However, induction of IL-6 production was significant in the presence of both 1 mm 8-bromo-cAMP and 100 nm PMA ( Table 1 ). The selective PKA inhibitor, H-89 (35), was used to study the role of PKA in IL-6 production induced by CT. IL-6 production was not affected by 20 m H-89 and was completely inhibited by 50 m H-89 (Fig. 4A) . Moreover, the specific inhibitor of both conventional and novel PKC isoforms, GF109203X (36) , was used to study the role of PKC on CT-induced IL-6 production. GF109203X caused a concentration-dependent inhibition of IL-6 production stimulated by CT, and inhibition was complete in the presence of 50 m GF109203X (Fig. 4B ). IL-6 was not detected in the presence of 50 m H-89 or 50 m GF109203X alone (data not shown).
FIG. 2. Effects of rCT, rCGRP, or rat amylin on cAMP accumulation
in TtT/GF cells. A, Cells were stimulated with the indicated concentrations of rCT, rCGRP, and rat amylin. B, Cells were stimulated with 100 nM rCT in the presence or absence of 100 nM sCT-(8 -32), 10 M rCGRP-(8 -37), or 10 M rat amylin-(8 -37). C, Cells were stimulated with 100 nM rCGRP in the presence or absence of 10 M rCGRP- (8 -37) . D, Cells were stimulated with 100 nM rat amylin in the presence or absence of 10 M rat amylin- (8 -37) . cAMP accumulation was determined as described in Materials and Methods. Data are the mean Ϯ SEM of at least three independent experiments. *, P Ͻ 0.05 compared with control.
Effects of signaling inhibitors on CT-induced IL-6 production
It has been reported that CT activates G proteins, MAPK, PLC, and PLD in addition to activating PKA and PKC (12) (13) (14) (15) (16) (17) (18) (19) . MAPK kinase-1 inhibitor, PD98059 (37) (10 m), reduced CT-induced IL-6 production to 67 Ϯ 3% and the inhibitory effect of PD98059 was consistent up to 50 m (46 Ϯ 3%; Fig.  5A ). Moreover, we examined the effects of PLC/PLD inhibitor, U73122 (38), on CT-induced IL-6 production. U73122 reduced CT-induced IL-6 production in a concentrationdependent manner, and inhibition by 50 m U73122 was 16 Ϯ 5% (Fig. 5B) . D609 is a PC-PLC inhibitor (39) , and propranolol, a ␤-adrenergic receptor antagonist, is a well established PPH inhibitor (40) . PLD catalyzes the hydrolysis of PC and generates phosphatidic acid, which is dephosphorylated by PPH to produce DG (45) . Thus, propranolol inhibits DG production via the PLD pathway. D609 and propranolol failed to suppress CT-induced IL-6 production in TtT/GF cells (Fig. 6 ). IL-6 was not detected in the presence of 50 m PD98059, 50 m U73122, 50 m D609, or 300 m propranolol alone (data not shown).
Inhibition of CT-induced IL-6 production by G i /G o proteins
PTX was used to investigate whether CT mediates G i /G o proteins. PTX covalently modifies the ␣-subunits of G i and G o proteins, resulting in the prevention of G i /G o protein activation (41) . The effects of 1 g/ml PTX on cAMP accu- TtT/GF cells were incubated with various agents for 6 h in serumfree medium. IL-6 released into the medium was assayed by ELISA. Data are the mean Ϯ SEM of at least three independent experiments. mulation were examined (Table 2) . Although PTX alone did not affect cAMP accumulation, PTX increased CT-induced cAMP accumulation approximately 2.5-fold. Moreover, 0.5 and 1 g/ml PTX treatment increased CT-induced IL-6 production to 871 Ϯ 135% and 806 Ϯ 52%, respectively (Fig. 7) . IL-6 was not detected in the presence of 0.5 g/ml PTX alone and was induced slightly in the presence of 1 g/ml PTX alone (44.4 Ϯ 17.7 pg/ml).
Discussion
The C1a subtype of CTR mRNA was expressed in the mouse pituitary and TtT/GF cells. As some secretory anterior pituitary cells, such as thyrotrophs, also express CTR (46) , the C1a mRNA in the mouse pituitary is derived from not only FS cells, but also other anterior pituitary cells. On the other hand, the mRNA of the C1b subtype was not detected in either mouse pituitary or TtT/GF cells. C1b is considered to be a receptor for endogenous sCT-like peptides (47) (48) (49) . The physiological plasma level of CT in rats is approximately 60 pg/ml (0.02 nm) to 480 pg/ml (0.1 nm) (50) . Although these levels of CT are able to increase cAMP accumulation, these concentrations of CT are not able to increase IL-6 production from FS cells. On the other hand, the pituitary also synthesizes and secretes CT-like peptides (47, 48) . Therefore, it is speculated that CT alone in the pituitary or in combination with plasma CT may induce IL-6 production from FS cells.
The receptor activity-modifying proteins (RAMPs) are a family of three single transmembrane proteins, RAMP1, -2, and -3, that modify the glycosylation of CTR-like receptor (CRLR) and are coexpressed with CRLR. RAMP1 is necessary for CRLR to act as CGRP receptor; RAMP2 or RAMP3 must be present for CRLR to act as an adrenomedullin receptor (51) . It has been demonstrated that high affinity amylin receptor-like phenotypes consist of CTR and RAMPs (52, 53) , but it remains unclear which subtype of RAMP is necessary for CT activation. Although CT, CGRP, and amylin activate their own receptors, high concentrations of CGRP or amylin interact with CTR (35, 36) . We examined the inhibitory effects of CT, CGRP, and amylin antagonists on CTinduced cAMP accumulation. CT-induced cAMP accumulation was inhibited strongly by sCT- (8 -32) and weakly by CGRP- (8 -37) . However, amylin-(8 -37) had no effect on CTinduced cAMP accumulation. We confirmed that CGRP and CT cross-react at high concentrations, but we also demonstrated that CT will primarily activate its own receptor.
The FS cell is a unique type of cell that forms follicles or ductules into which their own apical cell surfaces can project 
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TtT/GF cells were preincubated with 1 g/ml PTX for 16 h and then incubated with 1 M CT for 10 min. cAMP accumulation was determined as described in Materials and Methods. Data are the mean Ϯ SEM of at least three independent experiments. microvilli and cilia. Because of their localization and appearance, it seems that FS cells regulate hormone secretion and/or the metabolism of granulated pituitary cells. It has been shown that FS cells produce growth factors, including IL-6 (32, 33, 54 -57). IL-6 production is positively and negatively regulated by a variety of signals, namely lipopolysaccharide, cytokines, cAMP, and DG (26 -28) . Both cAMP and PMA were necessary for increasing IL-6 production in TtT/GF cells. Moreover, CT-induced IL-6 production was also inhibited by both the PKA-selective inhibitor, H-89, and the PKC-selective inhibitor, GF109203X. These findings indicate that both PKA and PKC are necessary for CT-induced IL-6 production. In addition to PKA and PKC, MAPK, PLC, and PLD are also involved in the CT signaling pathways (15) (16) (17) 19) . In TtT/GF cells, a MAPK-selective inhibitor, PD98059 partially inhibited CT-induced IL-6 production. U73122 is a PLC/PLD inhibitor that was previously thought to be a specific phosphatidylinositol-PLC inhibitor (38) . U73122 inhibited IL-6 production stimulated by CT. However, the PC-PLC inhibitor, D609, and the PLD inhibitor, propranolol, failed to suppress CT-induced IL-6 production. These findings imply that CT induces DG by PI-PLC, but not by PC-PLC or PLD, in TtT/GF cells. Recent studies have shown that G s , G q , and G i /G o proteins are all involved in the CTR signaling pathways (12) (13) (14) . In the present study we demonstrated that a G i /G o inhibitor, PTX, increased CTstimulated cAMP and IL-6 production. On the other hand, PTX alone produced no significant or only a slight increase in cAMP accumulation and IL-6 production. These findings indicate that CT also activates G i /G o proteins, which suppress cAMP accumulation and IL-6 production. Recently, it was reported that RAMPs decrease CT-induced cAMP accumulation in COS-7 cells expressing levels of human CTR (53) .
In this regard, it is of interest whether RAMPs can modify the ability of G i /G o proteins to couple to the CTR. In conclusion, we demonstrated that CT stimulates IL-6 production via both PKA and PKC pathways. However, CT also activates G i /G o proteins and negatively regulates IL-6 production in TtT/GF cells.
